50,000 Shares in Cognex Corporation $CGNX Acquired by Bokf Na

Key Points

• Bokf Na initiated a new position in Cognex during the fourth quarter, buying 50,000 shares valued at about $1.8 million. Other institutional investors also increased holdings, and institutions now own 88.12% of the company.
• Cognex reported strong Q1 results, with earnings of $0.34 per share beating estimates and revenue of $268.4 million topping forecasts and rising 24.3% year over year. The company also issued upbeat Q2 guidance for EPS of $0.40 to $0.44.
• Analyst sentiment has improved after the earnings release, with firms like Needham and Stephens raising price targets to $75. Cognex also announced a quarterly dividend of $0.085 per share, yielding about 0.5%.

Bokf Na bought a new position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 50,000 shares of the scientific and technical instruments company's stock, valued at approximately $1,799,000.

Other large investors have also added to or reduced their stakes in the company. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Cognex by 18.6% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 17,329 shares of the scientific and technical instruments company's stock valued at $623,000 after buying an additional 2,718 shares in the last quarter. Oppenheimer & Co. Inc. raised its holdings in Cognex by 87.4% during the fourth quarter. Oppenheimer & Co. Inc. now owns 30,917 shares of the scientific and technical instruments company's stock valued at $1,112,000 after acquiring an additional 14,417 shares during the period. Certuity LLC purchased a new position in shares of Cognex in the fourth quarter valued at about $220,000. M&T Bank Corp boosted its stake in shares of Cognex by 58.0% in the fourth quarter. M&T Bank Corp now owns 80,511 shares of the scientific and technical instruments company's stock worth $2,897,000 after acquiring an additional 29,546 shares during the period. Finally, Pictet Asset Management Holding SA boosted its stake in shares of Cognex by 27.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company's stock worth $252,360,000 after acquiring an additional 1,529,010 shares during the period. Hedge funds and other institutional investors own 88.12% of the company's stock.

Cognex Stock Down 0.4%

CGNX opened at $65.66 on Friday. The business has a fifty day moving average of $52.67 and a 200 day moving average of $45.20. The stock has a market cap of $10.97 billion, a P/E ratio of 78.17 and a beta of 1.48. Cognex Corporation has a 52-week low of $29.00 and a 52-week high of $71.90.

Cognex (NASDAQ:CGNX - Get Free Report) last released its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The business had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. During the same quarter last year, the firm posted $0.14 earnings per share. The business's revenue was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Equities analysts anticipate that Cognex Corporation will post 0.97 EPS for the current fiscal year.

Cognex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st will be paid a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Thursday, May 21st. Cognex's dividend payout ratio is currently 40.48%.

Key Cognex News

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Cognex reported Q1 earnings of $0.34 per share, beating estimates, while revenue came in at $268.4 million, also above expectations and up 24.3% year over year.
• Positive Sentiment: Management issued bullish Q2 guidance for EPS of $0.40 to $0.44 and revenue of $280 million to $300 million, signaling continued demand strength in automation and logistics.
• Positive Sentiment: Analysts turned more constructive after the report: Needham raised its price target to $75 and kept a Buy rating, while Stephens also lifted its target to $75 with an Overweight rating.
• Positive Sentiment: The company’s new AI-powered In-Sight systems and broad-based demand strength are reinforcing the view that Cognex can sustain growth and margin expansion.
• Neutral Sentiment: JPMorgan raised its price target to $65 but maintained a Neutral rating, suggesting some analysts still see limited upside after the recent run-up. Benzinga
• Neutral Sentiment: The company also declared a quarterly dividend of $0.085 per share, a modest positive for income-focused investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Raymond James Financial reiterated a "strong-buy" rating on shares of Cognex in a research report on Thursday, February 12th. KeyCorp reaffirmed an "overweight" rating and set a $70.00 target price (up from $50.00) on shares of Cognex in a research note on Friday, February 13th. Wall Street Zen upgraded shares of Cognex from a "hold" rating to a "buy" rating in a report on Saturday. Sanford C. Bernstein reiterated an "outperform" rating and issued a $75.00 price target on shares of Cognex in a research note on Thursday. Finally, Stephens increased their price objective on shares of Cognex from $65.00 to $75.00 and gave the company an "overweight" rating in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $67.21.

Insiders Place Their Bets

In other Cognex news, Director Angelos Papadimitriou sold 4,150 shares of the firm's stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $55.58, for a total transaction of $230,657.00. Following the transaction, the director directly owned 16,222 shares in the company, valued at $901,618.76. This trade represents a 20.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Laura Ann Macdonald sold 14,881 shares of Cognex stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $57.16, for a total value of $850,597.96. Following the sale, the vice president directly owned 2,212 shares of the company's stock, valued at approximately $126,437.92. This trade represents a 87.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 196,083 shares of company stock worth $11,419,321 in the last three months. Corporate insiders own 1.70% of the company's stock.

Cognex Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.